Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 33 results.
User Information
Export Records
  1. 1.   Serum and Cervicovaginal Fluid Antibody Profiling in Herpes Simplex Virus (HSV) Seronegative Recipients of the HSV529 Vaccine
  2. Wang, Kening; Dropulic, Lesia; Bozekowski, Joel; Pietz, Harlan L; Jegaskanda, Sinthujan; Dowdell, Kennichi; Vogel, Joshua S; Garabedian, Doreen; Oestreich, Makinna; Nguyen, Hanh; Ali, Mir A; Lumbard, Keith; Hunsberger, Sally; Reifert, Jack; Haynes, Winston A; Sawyer, Jaymie R; Shon, John C; Daugherty, Patrick S; Cohen, Jeffrey I
  3. The Journal of Infectious Diseases. 2021, Nov 16; 224(9): 1509-1519.
  1. 2.   Neopapillarine, an Unusual Coumarino-Alkaloid from the Root Extract of Neocryptodiscus papillaris with Cytotoxic Activity on Renal Cancer Cells
  2. Tosun, Fatma; Mihoglugil, Feyyaz; Beutler,John; Eroglu Özkan, Esra; Miski, Mahmut
  3. Molecules (Basel, Switzerland). 2020, Jul 03; 25(13):
  1. 3.   A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Study of a Replication-Defective Herpes Simplex Virus 2 Vaccine, HSV529, in Adults With or Without HSV Infection
  2. Dropulic, Lesia K; Oestreich, Makinna C; Pietz, Harlan L; Laing, Kerry J; Hunsberger, Sally; Lumbard,Keith; Garabedian,Doreen; Turk, Siu Ping; Chen, Aiying; Hornung, Ronald L; Seshadri, Chetan; Smith, Malisa T; Hosken, Nancy A; Phogat, Sanjay; Chang, Lee-Jah; Koelle, David M; Wang, Kening; Cohen, Jeffrey I
  3. The Journal of infectious diseases. 2019, SEP 15; 220(6): 990-1000.
  1. 4.   Genomic HIV RNA Induces Innate Immune Responses through RIG-I-Dependent Sensing of Secondary-Structured RNA
  2. Berg, R. K.; Melchjorsen, J.; Rintahaka, J.; Diget, E.; Soby, S.; Horan, K. A.; Gorelick, R. J.; Matikainen, S.; Larsen, C. S.; Ostergaard, L.; Paludan, S. R.; Mogensen, T. H.
  3. Plos One. 2012, Jan; 7(1):
  1. 5.   Vaccine Protection against Simian Immunodeficiency Virus in Monkeys Using Recombinant Gamma-2 Herpesvirus
  2. Bilello, J. P.; Manrique, J. M.; Shin, Y. C.; Lauer, W.; Li, W. J.; Lifson, J. D.; Mansfield, K. G.; Johnson, R. P.; Desrosiers, R. C.
  3. Journal of Virology. 2011, Dec; 85(23): 12708-12720.
  1. 6.   Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaques
  2. Kulkarni, V.; Jalah, R.; Ganneru, B.; Bergamaschi, C.; Alicea, C.; von Gegerfelt, A.; Patel, V.; Zhang, G. M.; Chowdhury, B.; Broderick, K. E.; Sardesai, N. Y.; Valentin, A.; Rosati, M.; Felber, B. K.; Pavlakis, G. N.
  3. Vaccine. 2011, Sep; 29(39): 6742-6754.
  1. 7.   HSV-2 Infection of Dendritic Cells Amplifies a Highly Susceptible HIV-1 Cell Target
  2. Martinelli, E.; Tharinger, H.; Frank, I.; Arthos, J.; Piatak, M.; Lifson, J. D.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos Pathogens. 2011, Jun; 7(6): 14.
  1. 8.   Highly Efficient Method for C-5 Halogenation of Pyrimidine-Based Nucleosides in Ionic Liquids
  2. Kumar, V.; Yap, J.; Muroyama, A.; Malhotra, S. V.
  3. Synthesis-Stuttgart. 2009, Dec; (23): 3957-3962.
  1. 9.   The Nucleoside Analogue D-carba T Blocks HIV-1 Reverse Transcription
  2. Boyer, P. L.; Vu, B. C.; Ambrose, Z.; Julias, J. G.; Warnecke, S.; Liao, C. Z.; Meier, C.; Marquez, V. E.; Hughes, S. H.
  3. Journal of Medicinal Chemistry. 2009 52(17): 5356-5364.
  1. 10.   A Macaque Model to Study Vaginal HSV-2/Immunodeficiency Virus Co-Infection and the Impact of HSV-2 on Microbicide Efficacy
  2. Crostarosa, F.; Aravantinou, M.; Akpogheneta, O. J.; Jasny, E.; Shaw, A.; Kenney, J.; Piatak, M.; Lifson, J. D.; Teitelbaum, A.; Hu, L. Y.; Chudolij, A.; Zydowsky, T. M.; Blanchard, J.; Gettie, A.; Robbiani, M.
  3. Plos One. 2009 4(11):
  1. 11.   Acyclovir is activated into a HIV-1 reverse transcriptase inhibitor in herpesvirus-infected human tissues
  2. Lisco, A.; Vanpouille, C.; Tchesnokov, E. P.; Grivel, J. C.; Biancotto, A.; Brichacek, B.; Elliott, J.; Fromentin, E.; Shattock, R.; Anton, P.; Gorelick, R.; Balzarini, J.; McGuigan, C.; Derudas, M.; Gotte, M.; Schinazi, R. F.; Margolis, L.
  3. Cell Host & Microbe. 2008 4(3): 260-270.
  1. 12.   The nucleoside analogs 4 ' C-Methyl thymidine and 4 ' C-Ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants
  2. Boyer, P. L.; Julias, J. G.; Ambrose, Z.; Siddiqui, M. A.; MarqueZ, V. E.; Hughes, S. H.
  3. Journal of Molecular Biology. 2007, Aug; 371(4): 873-882.
  1. 13.   Hairpin- and cruciform-mediated chromosome breakage: causes and consequences in eukaryotic cells
  2. Lobachev, K. S.; Rattray, A.; Narayanan, V.
  3. Frontiers in Bioscience. 2007, May; 12: 4208-4220.
  1. 14.   Defensin participation in innate and adaptive immunity
  2. Yang, D.; Liu, Z. H.; Tewary, P.; Chen, Q.; De la Rosa, G.; Oppenheim, J. J.
  3. Current Pharmaceutical Design. 2007 13(30): 3131-3139.
  1. 15.   Backbone conformational preferences and pseudorotational ring puckering of 1-aminocyclopentane-1-carboxylic acid
  2. Aleman, C.; Zanuy, D.; Casanovas, J.; Cativiela, C.; Nussinov, R.
  3. Journal of Physical Chemistry B. 2006, Oct; 110(42): 21264-21271.
  1. 16.   Critical design features of phenyl carboxylate-containing polymer microbicides
  2. Rando, R. F.; Obara, S.; Osterling, M. C.; Mankowski, M.; Miller, S. R.; Ferguson, M. L.; Krebs, F. C.; Wigdahl, B.; Labib, M.; Kokub, H.
  3. Antimicrobial Agents and Chemotherapy. 2006, Sep; 50(9): 3081-3089.
  1. 17.   The history of N-methanocarbathymidine: The investigation of a conformational concept leads to the discovery of a potent and selective nucleoside antiviral agent
  2. Marquez, V. E.; Hughes, S. H.; Sei, S.; Agbaria, R.
  3. Antiviral Research. 2006, Sep; 71(2-3): 268-275.
  1. 18.   The RIO kinases: An atypical protein kinase family required for ribosome biogenesis and cell cycle progression
  2. Laronde-Leblanc, N.; Wlodawer, A.
  3. Biochimica Et Biophysica Acta-Proteins and Proteomics. 2005, DEC 30; 1754(1-2, Sp. Iss.): 14-24.
  1. 19.   Potent antiviral activity of North-methanocarbathymidine against Kaposi's sarcoma-associated herpesvirus
  2. Zhu, W. M.; Burnette, A.; Dorjsuren, D.; Roberts, P. E.; Huleihel, M.; Shoemaker, R. H.; Marquez, V. E.; Agbaria, R.; Sei, S.
  3. Antimicrobial Agents and Chemotherapy. 2005, DEC; 49(12): 4965-4973.
  1. 20.   Understanding how the herpes thymidine kinase orchestrates optimal sugar and nucleobase conformations to accommodate its substrate at the active site: A chemical approach
  2. Marquez, V. E.; Choi, Y.; Comin, M. J.; Russ, P.; George, C.; Huleihel, M.; Ben-Kasus, T.; Agbaria, R.
  3. Journal of the American Chemical Society. 2005, NOV 2; 127(43): 15145-15150.
  1. 21.   Heparan sulfate Proteoglycans mediate attachment and entry of human T-cell leukemia virus type 1 virions into CD4(+) T cells
  2. Jones, K. S.; Petrow-Sadowski, C.; Bertolette, D. C.; Huang, Y.; Ruscetti, F. W.
  3. Journal of Virology. 2005, OCT; 79(20): 12692-12702.
  1. 22.   Dynamics of the antiviral activity of N-methanocarbathymidine against herpes simplex virus type 1 in cell culture
  2. Huleihel, M.; Talishanisky, M.; Ford, H.; Marquez, V. E.; Kelley, J. A.; Johns, D. G.; Agbaria, R.
  3. International Journal of Antimicrobial Agents. 2005, MAY; 25(5): 427-432.
  1. 23.   TRAF2 plays a key, nonredundant role in LIGHT-lymphotoxin beta receptor signaling
  2. Kim, Y. S.; Nedospasov, S. A.; Liu, Z. G.
  3. Molecular and Cellular Biology. 2005, MAR; 25(6): 2130-2137.
  1. 24.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 25.   Experimental and structural evidence that herpes 1 kinase and cellular DNA polymerase(s) discriminate on the basis of sugar pucker
  2. Marquez, V. E.; Ben Kasus, T.; Barchi, J. J.; Green, K. M.; Nicklaus, M. C.; Agbaria, R.
  3. Journal of the American Chemical Society. 2004 126(2): 543-549.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel